Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001615774-18-001750
Filing Date
2018-03-09
Accepted
2018-03-09 15:32:54
Documents
1
Period of Report
2016-02-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 s109297_form4.html 4  
1 FORM 4 s109297_form4.xml 4 16397
  Complete submission text file 0001615774-18-001750.txt   17853
Mailing Address 20 FAIRMOUNT AVENUE P.O. BOX 445 CHATHAM NJ 07928
Business Address
MARIO ERNEST (Reporting) CIK: 0001180469 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36019 | Film No.: 18679918

Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Issuer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations